Multiple sclerosis activated by anti-tumor necrosis factor α (Etanercept) and the genetic risk.
Division of Neurology, Regina Elena National Cancer Institute, IFO, Rome, Italy.
Edvina
E
Galiè
Division of Neurology, Regina Elena National Cancer Institute, IFO, Rome, Italy.
Bruno
B
Jandolo
Division of Clinical Pathology, Regina Elena National Cancer Institute, IFO, Rome, Italy.
Alyne
A
Martayane
Division of Neurology, Regina Elena National Cancer Institute, IFO; Institute of Neurology, Catholic University of Sacred Heart, Rome, Italy.
Rosaria
R
Renna
Division of Neurology, Regina Elena National Cancer Institute, IFO; Department of Systems Medicine, Tor Vergata University, Rome, Italy.
Tatiana
T
Koudriavtseva
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000068800:Etanercept / Q000009:adverse effects*; D006801:Humans; D009103:Multiple Sclerosis / Q000139:chemically induced*; D012307:Risk Factors
D000911:Antibodies, Monoclonal; D000068800:Etanercept